Your browser doesn't support javascript.
loading
The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene.
Hahn, Leo C; Georgiou, Michalis; Almushattat, Hind; van Schooneveld, Mary J; de Carvalho, Emanuel R; Wesseling, Nieneke L; Ten Brink, Jacoline B; Florijn, Ralph J; Lissenberg-Witte, Birgit I; Strubbe, Ine; van Cauwenbergh, Caroline; de Zaeytijd, Julie; Walraedt, Sophie; de Baere, Elfride; Mukherjee, Rajarshi; McKibbin, Martin; Meester-Smoor, Magda A; Thiadens, Alberta A H J; Al-Khuzaei, Saoud; Akyol, Engin; Lotery, Andrew J; van Genderen, Maria M; Ossewaarde-van Norel, Jeannette; van den Born, L Ingeborgh; Hoyng, Carel B; Klaver, Caroline C W; Downes, Susan M; Bergen, Arthur A; Leroy, Bart P; Michaelides, Michel; Boon, Camiel J F.
Afiliação
  • Hahn LC; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Georgiou M; Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
  • Almushattat H; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • van Schooneveld MJ; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; Bartiméus Diagnostic Center for Complex Visual Disorders, Zeist, The Netherlands.
  • de Carvalho ER; Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
  • Wesseling NL; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Ten Brink JB; Department of Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Florijn RJ; Department of Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Lissenberg-Witte BI; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Strubbe I; Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium.
  • van Cauwenbergh C; Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium; Center for Medical Genetics Ghent, Ghent University Hospital & Ghent University, Ghent, Belgium.
  • de Zaeytijd J; Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium.
  • Walraedt S; Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium.
  • de Baere E; Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium; Center for Medical Genetics Ghent, Ghent University Hospital & Ghent University, Ghent, Belgium.
  • Mukherjee R; Department of Ophthalmology, St James's University Hospital, Leeds, United Kingdom.
  • McKibbin M; Department of Ophthalmology, St James's University Hospital, Leeds, United Kingdom.
  • Meester-Smoor MA; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Thiadens AAHJ; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Al-Khuzaei S; Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals National Health Service Foundation Trust, & Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom.
  • Akyol E; Eye Unit, University Hospital Southampton, Southampton, United Kingdom.
  • Lotery AJ; Eye Unit, University Hospital Southampton, Southampton, United Kingdom.
  • van Genderen MM; Bartiméus Diagnostic Center for Complex Visual Disorders, Zeist, The Netherlands; Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Ossewaarde-van Norel J; Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van den Born LI; The Rotterdam Eye Hospital and the Rotterdam Ophthalmic Institute, Rotterdam, The Netherlands.
  • Hoyng CB; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Klaver CCW; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Downes SM; Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals National Health Service Foundation Trust, & Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom.
  • Bergen AA; Department of Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; The Netherlands Institute for Neuroscience (NIN-KNAW), Amsterdam, The Netherlands.
  • Leroy BP; Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium; Center for Medical Genetics Ghent, Ghent University Hospital & Ghent University, Ghent, Belgium; Division of Ophthalmology and Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadel
  • Michaelides M; Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.
  • Boon CJF; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: Camiel.boon@amsterdamumc.nl.
Ophthalmol Retina ; 6(8): 711-722, 2022 08.
Article em En | MEDLINE | ID: mdl-35314386
ABSTRACT

OBJECTIVE:

To describe the spectrum of Leber congenital amaurosis (LCA) and cone-rod dystrophy (CORD) associated with the GUCY2D gene and to identify potential end points and optimal patient selection for future therapeutic trials.

DESIGN:

International, multicenter, retrospective cohort study.

SUBJECTS:

Eighty-two patients with GUCY2D-associated LCA or CORD from 54 families.

METHODS:

Medical records were reviewed for medical history, best-corrected visual acuity (BCVA), ophthalmoscopy, visual fields, full-field electroretinography, and retinal imaging (fundus photography, spectral-domain OCT [SD-OCT], fundus autofluorescence). MAIN OUTCOMES

MEASURES:

Age of onset, evolution of BCVA, genotype-phenotype correlations, anatomic characteristics on funduscopy, and multimodal imaging.

RESULTS:

Fourteen patients with autosomal recessive LCA and 68 with autosomal dominant CORD were included. The median follow-up times were 5.2 years (interquartile range [IQR] 2.6-8.8 years) for LCA and 7.2 years (IQR 2.2-14.2 years) for CORD. Generally, LCA presented in the first year of life. The BCVA in patients with LCA ranged from no light perception to 1.00 logarithm of the minimum angle of resolution (logMAR) and remained relatively stable during follow-up. Imaging for LCA was limited but showed little to no structural degeneration. In patients with CORD, progressive vision loss started around the second decade of life. The BCVA declined annually by 0.022 logMAR (P < 0.001) with no difference between patients with the c.2513G>A and the c.2512C>T GUCY2D variants (P = 0.798). At the age of 40 years, the probability of being blind or severely visually impaired was 32%. The integrity of the ellipsoid zone (EZ) and that of the external limiting membrane (ELM) on SD-OCT correlated significantly with BCVA (Spearman ρ = 0.744, P = 0.001, and ρ = 0.712, P < 0.001, respectively) in those with CORD.

CONCLUSIONS:

Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy and available imaging, suggesting long preservation of photoreceptors. Despite large variability, GUCY2D-associated CORD generally presented during adolescence, with a progressive loss of vision, and culminated in severe visual impairment during mid-to-late adulthood. The integrity of the ELM and EZ may be suitable structural end points for therapeutic studies of GUCY2D-associated CORD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amaurose Congênita de Leber / Distrofias de Cones e Bastonetes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ophthalmol Retina Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amaurose Congênita de Leber / Distrofias de Cones e Bastonetes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ophthalmol Retina Ano de publicação: 2022 Tipo de documento: Article